Active Pharmaceutical Ingredient Market

Active Pharmaceutical Ingredient Market Market Set to Exceed USD 306.1 Billion By 2027 | CAGR: 7.1%

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

“Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2020 - 2027” The global active pharmaceutical ingredient (API) market size is expected to reach USD 306.1 billion by 2027 according to a new study by Polaris Market Research. The report “Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; Segment Forecast, 2020 –2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.

Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body. Drug products are composed of various components, API is the primary ingredient of a drug product, for instance, capsule or a tablet. APIs form used in the formulation is the most stable crystalline form, thermo-dynamically.

Browse Detailed Research Report On Active Pharmaceutical Ingredient Market Analysis:

https://www.polarismarketresearch.com/industry-analysis/active-pharmaceuticalingredients-market The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth.

Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs. For instance, according to a report published in March 2020, by World Health Organization (WHO), the number of COVID-19 patients increased to 200,000 and in almost after twelve-day period, the number would exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global market.

Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy’s Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market.

-2-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising demand of critical drugs for the treatment of numerous diseases. For the treatment of various diseases such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, which are responsible for the majority of deaths across the globe, the innovation and demand for pharmaceuticals has witnessed elevated graph over the few decades. This has further resulted in rise in growth of API during the past years and also over the forecast period.

Major players in the market are strengthening their capabilities to enhance their product portfolio and further establish their market place. For instance, on July, 2020, Advert International signed an agreement for the acquisition of RA Chem Pharma Ltd, an integrated pharmaceutical company by Micro Labs Ltd. for USD 1.7 billion. Advert International aims for building one of the major API platforms and is expected to leverage their operational and financial resources across the globe to scale RA Chem Pharma.

Request for sample: https://www.polarismarketresearch.com/industry-analysis/active-

pharmaceutical-ingredients-market/request-for-sample TABLE OF CONTENTS

•

• •

Introduction o Report Description ▪ Objectives of the Study ▪ Market Scope ▪ Assumptions o Stakeholders Executive Summary o Market Highlights Research Methodology o Overview ▪ Data Mining o Data Sources ▪ Primary Sources ▪ Secondary Sources -3-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

•

•

Active Pharmaceutical Ingredient Market Insights o Active Pharmaceutical Ingredient – Industry snapshot o Active Pharmaceutical Ingredient Market Dynamics ▪ Drivers and Opportunities • Surge in the infectious diseases • Growing Importance of Generics ▪ Restraints and Challenges • Side effects associated of drugs o Porter’s Five Forces Analysis ▪ Bargaining Power of Suppliers (Moderate) ▪ Threats of New Entrants: (Low) ▪ Bargaining Power of Buyers (Moderate) ▪ Threat of Substitute (Moderate) ▪ Rivalry among existing firms (High) o PESTLE Analysis o Active Pharmaceutical Ingredient Market Industry trends Active Pharmaceutical Ingredient Market Assessment by Product Type o Key Findings o Introduction ▪ Global Active Pharmaceutical Ingredient Market, By Product Type, 2015 – 2026 (USD Million) o Monoclonal Antibodies ▪ Global Active Pharmaceutical Ingredient Market, by Monoclonal Antibodies, by Region, 2016- 2027 (USD Million) o Immunoglobulin ▪ Global Active Pharmaceutical Ingredient Market, by Immunoglobulin, by Region, 2016- 2027 (USD Million) o Cytokines ▪ Global Active Pharmaceutical Ingredient Market, by Cytokines, by Region, 2016- 2027 (USD Million) o Insulin ▪ Global Active Pharmaceutical Ingredient Market, by Insulin, by Region, 2016- 2027 (USD Million) o Peptide Hormones ▪ Global Active Pharmaceutical Ingredient Market, by Peptide Hormones, by Region, 2016- 2027 (USD Million) o Blood Factors ▪ Global Active Pharmaceutical Ingredient Market, by Blood Factors, by Region, 2016- 2027 (USD Million) o Peptide Antibiotics ▪ Global Active Pharmaceutical Ingredient Market, by Peptide Antibiotics, by Region, 2016- 2027 (USD Million) o Vaccines ▪ Global Active Pharmaceutical Ingredient Market, by Vaccines, by Region, 2016- 2027 (USD Million) o Small Molecule Antibiotics ▪ Global Active Pharmaceutical Ingredient Market, by Small Molecule Antibiotics, by Region, 2016- 2027 (USD Million) o Highly Potent Active Pharmaceutical Ingredient (HPAPI) ▪ Global Active Pharmaceutical Ingredient Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2016- 2027 (USD Million) o Others -4-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

▪

•

•

•

Global Active Pharmaceutical Ingredient Market, by Others, by Region, 2016- 2027 (USD Million) Global Active Pharmaceutical Ingredient Market, by Form o Key Findings o Introduction ▪ Global Active Pharmaceutical Ingredient Market, By Form, 2015 – 2026 (USD Million) o Aqueous ▪ Global Active Pharmaceutical Ingredient Market, by Aqueous, By Region, 2016- 2027 (USD Million) o Non-Aqueous Liquid ▪ Global Active Pharmaceutical Ingredient Market, by Non-Aqueous Liquid,

by Region, 2016- 2027 (USD Million) o Dry Powder ▪ Global Active Pharmaceutical Ingredient Market, by Dry Powder, by Region, 2016- 2027 (USD Million) Global Active Pharmaceutical Ingredient Market, by Manufacturer o Key Findings o Introduction ▪ Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2015 – 2026 (USD Million) o Captive ▪ Global Active Pharmaceutical Ingredient Market, by Captive, By Region, 2016- 2027 (USD Million) o Merchant ▪ Global Active Pharmaceutical Ingredient Market, by Merchant, by Region, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market Assessment by Application o Key Findings o Introduction ▪ Global Active Pharmaceutical Ingredient Market, By Application, 2015 – 2026 (USD Million) o Cardiology ▪ Global Active Pharmaceutical Ingredient Market, by Cardiology, by Region, 2016- 2027 (USD Million) o Oncology ▪ Global Active Pharmaceutical Ingredient Market, by Oncology, by Region, 2016- 2027 (USD Million) o CNS & Neurology ▪ Global Active Pharmaceutical Ingredient Market, by CNS & Neurology, by Region, 2016- 2027 (USD Million) o Orthopedic ▪ Global Active Pharmaceutical Ingredient Market, by Orthopedic, by Region, 2016- 2027 (USD Million) o Endocrinology ▪ Global Active Pharmaceutical Ingredient Market, by Endocrinology, by Region, 2016- 2027 (USD Million) o Pulmonology ▪ Global Active Pharmaceutical Ingredient Market, by Pulmonology, by Region, 2016- 2027 (USD Million) o Gastroenterology

-5-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

▪

•

Global Active Pharmaceutical Ingredient Market, by Gastroenterology, by Region, 2016- 2027 (USD Million) o Nephrology ▪ Global Active Pharmaceutical Ingredient Market, by Nephrology, by Region, 2016- 2027 (USD Million) o Ophthalmology ▪ Global Active Pharmaceutical Ingredient Market, by Ophthalmology, by Region, 2016- 2027 (USD Million) o Others ▪ Global Active Pharmaceutical Ingredient Market, by Other Applications, by Region, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market Assessment by Geography o Key findings o Introduction ▪ Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million) o Active Pharmaceutical Ingredient Market – North America ▪ North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) ▪ North America: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) ▪ North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million) ▪ North America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – U.S. • U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • U.S.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Canada • Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Canada.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Canada: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) o Active Pharmaceutical Ingredient Market – Europe ▪ Europe: Active Pharmaceutical Ingredient Market, By Product Type, 20162027 (USD Million) ▪ Europe.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) ▪ Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 20162027 (USD Million) ▪ Europe: Active Pharmaceutical Ingredient Market, By Application, 20162027 (USD Million) -6-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

▪

▪

▪

▪

▪

▪

Active Pharmaceutical Ingredient Market – UK • UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • UK.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • UK: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market – France • France: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • France.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • France: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market – Germany • Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Germany.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Germany: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market – Italy • Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Italy.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Italy: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market – Spain • Spain: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Spain.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Spain: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Spain: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) Active Pharmaceutical Ingredient Market – Netherlands • Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Netherlands.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)

-7-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

•

Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Austria • Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Austria.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Austria: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) o Active Pharmaceutical Ingredient Market – Asia-Pacific ▪ Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) ▪ Asia Pacific.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) ▪ Asia-pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) ▪ Asia-pacific: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – China • China: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • China.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • China: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – India • India: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • India.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • India: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Malaysia • Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Malaysia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Japan

-8-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

•

Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Japan.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Japan: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Indonesia • Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Indonesia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – South Korea • South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • South Korea.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) o Active Pharmaceutical Ingredient Market – Middle East & Africa ▪ Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) ▪ Middle East & Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) ▪ Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) ▪ Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Saudi Arabia • Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Saudi Arabia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – UAE • UAE: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • UAE.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • UAE: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) -9-

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

•

UAE: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Israel • Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Israel.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Israel: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – South Africa • South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • South Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) o Active Pharmaceutical Ingredient Market – Latin America ▪ Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) ▪ Latin America.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) ▪ Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) ▪ Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Mexico • Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Mexico.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Brazil • Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million) • Brazil.: Active Pharmaceutical Ingredient Market, By Form, 20162027 (USD Million) • Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) ▪ Active Pharmaceutical Ingredient Market – Argentina • Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)

- 10 -

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

•

•

•

Argentina.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million) • Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million) • Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million) Competitive Landscape o Expansion and Acquisition Analysis ▪ Expansion & Acquisition o Partnerships/Collaborations/Agreements/Exhibitions Company Profiles o AbbVie Inc. ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o Albemarle Corporation ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o AstraZeneca ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o Aurobindo Pharma ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o Boehringer Ingelheim ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o Bristol-Myers Squibb ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o Cipla Inc. ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o Dr. Reddy's Laboratories Ltd. ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development o ELI Lilly and Company - 11 -

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

o

o

o

o

o

o

o

o

o

o

▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development F. Hoffmann-La Roche AG ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development GlaxoSmithKline PLC ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Lonza Group ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Merck & Co., Inc. ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Mylan N.V. ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Novartis AG ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Pfizer, Inc. ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Sanofi ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Sun Pharmaceutical Industries Ltd ▪ Company Overview ▪ Financial Performance ▪ Product Benchmarking ▪ Recent Development Teva Pharmaceutical Industries Ltd. ▪ Company Overview ▪ Financial Performance - 12 -

Active Pharmaceutical Ingredient Market Size to Reach $306.1 Billion By 2027

â–Ş â–Ş

Product Benchmarking Recent Development

Access Press Release on Active Pharmaceutical Ingredient Market : https://www.polarismarketresearch.com/press-releases/active-pharmaceutical-ingredientmarket About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com

- 13 -